Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
Phase: N/A
Priority: Normal
Start: 08/07/24
End: 01/01/28
Due: 01/01/29
Phase: N/A
Priority: Normal
Start: 11/03/22
End: 08/31/27
Due: 08/31/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors | NCT06261814 | john eisenbrey | user2@example.com | None | 2024-08-07 | 2028-01-01 | 2029-01-01 | - | - | 2025-07-14 |
| Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation | NCT05641935 | john eisenbrey | user2@example.com | None | 2022-11-03 | 2027-08-31 | 2028-08-31 | - | - | 2025-07-14 |